RecruitingPhase 3NCT07234695

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Intervention
Levetiracetam 500mg(drug)
Enrollment
120 enrolled
Eligibility
40 years · All sexes
Timeline
20252028

Study locations (5)

Collaborators

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Hospital Universitario Marqués de Valdecilla · Fundación CITA Alzheimer · University Hospital Virgen de las Nieves

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07234695 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome

← Back to all trials